Econ Financial Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Buy
6,300
+1,903
+43% +$364K 0.64% 53
2026
Q1
$806K Buy
4,397
+451
+11% +$83.1K 0.37% 64
2025
Q4
$694K Buy
+3,946
New +$645K 0.35% 63

Other funds holding BIIB

Econ Financial Services's BIIB Position: Q2 2026 in Review

Econ Financial Services increased its Biogen (BIIB) stake by 43% in Q2 2026, buying an estimated $364K and bringing the position to 6,300 shares worth $1.36M. The position accounts for 0.64% of the portfolio, ranked #53.

Econ Financial Services first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 405 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Econ Financial Services held 6,300 shares of Biogen worth $1.36M as of Q2 2026.
  • Econ Financial Services bought 1,903 Biogen shares in Q2 2026, an estimated $364K.
  • Biogen made up 0.64% of Econ Financial Services's portfolio in Q2 2026, its #53 holding.
  • Econ Financial Services first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 405 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Econ Financial Services's 13F filing for Q2 2026, filed 23 Jul 2026.